Clinical Trials
4 trialsNCT06668584 2026-03-04
A Phase II Open-label Study of Olutasidenib Post-transplant Maintenance Therapy for Patients With IDH1-mutated Myeloid Malignancies
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT02452697 2024-02-20
NK-DCI
Duke University
Phase 2 Unknown
NCT05807659 2023-04-11
Fractionated Busulfan Conditioning Regimen for Allo-HSCT in Non-remission Myeloid Malignancies
Sichuan University
Phase 2 Unknown
NCT03270748 2023-03-10
GITMO-PHYLOS
Gruppo Italiano Trapianto di Midollo Osseo
Phase 2 Completed